Involvement of Oxidative Stress in Anticholinesterase Pesticide Toxicity

Anticholinesterase Pesticides: Metabolism, Neurotoxicity, and Epidemiology

Volumn , Issue , 2011, Pages 133-147

  Milatovic, Dejan ^a   Aschner, Michael ^a   Gupta, Ramesh C ^b   Zaja Milatovic, Snjezana ^a   Barnes, Gregory ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MURRAY STATE UNIVERSITY   (United States)

Author keywords

Anticholinesterase induced oxidative injury suppression; Oxidative stress, imbalance between free radical production and antioxidant defenses; Toxicity and biomonitoring oxidative stress in anticholinesterase pesticide toxicity

Indexed keywords

EID: 84885821489     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470640500.ch11     Document Type: Chapter

References (133)

1. Aldridge WN and Reiner E (1972) Acylated amino acids in inhibited B-esterases. In: A Neuberger and EL Tatum (Eds), Enzyme Inhibitors as Substrates. Amsterdam: North-Holland, pp. 170-175.
2. Andersen KA, Diaz PT, Wright VP and Clanton TL (1996) N-tertbutyl- alpha-phenylnitrone: a free radical trap with unanticipated effects on diaphragm function. J Appl Physiol 80:862-868.
3. Anderson DE, Yuan XJ, Tseng CM et al. (1993) Nitrone spin traps block calcium channels and induce pulmonary artery relaxation independent of free radicals. Biochem Biophys Res Commun 193:878-885.
4. Aschner M (2000) Interaction between pesticides and glia: an unexplored experimental field. NeuroToxicology 21:175-180.
5. Bagetta G, Iannanone M, Scorsa AM and Nistico G (1992) Tacrineinduced seizures and brain damage in LiCl-treated rats can be prevented by N-nitro-L-arginine methyl ester. Eur J Pharmacol 213:301-304.
6. Bagetta G, Massoud R, Rodino P, Federici G and Nistico G (1993) Systemic administration of lithium choloride and tacrine increases nitric oxide synthase activity in the hippocampus of rats. Eur J Pharmacol 237:61-64.
7. Barth A, Barth L and Newel DW (1996) Combination therapy with MK-801 and alpha-phenyl-tert-butylnitrone enhances protection against ischemic neuronal damage in organotypic hippocampal slice cultures. Exp Neurol 141:330-336.
8. Behan PD (1996) Chronic fatigue syndrome as a delayed reaction to low dose organophosphate exposure. J Nutrition Environ Med 6:341-350.
9. Bolanos JP, Peuchen S, Heales SJ, Land JM and Clark JB (1994) Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem 63:910-916.
10. Bondy SC and Lee DK (1993) Oxidative stress induced by glutamate receptor agonists. Brain Res 610:229-233.
11. Borges K, Gearing M, MacDermott DL, Smith AB, Almonte AG, Wainer BH and Dingledine R (2003) Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model. Exp Neurol 182:21-34.
12. Bose R, Schnell CP, Pinsky C and Zitko V (1992) Effects of excitotoxin on free radical indices in mouse brain. Toxicol Lett 60:211-219.
13. Bredt DS (1999) Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Rad Res 31:577-596.
14. Brorson JR, Scumacker PT and Zhang H (1999) Nitric oxide acutely inhibits neuronal energy production. The Committees on Neurobiology and Cell Physiology. J Neurosci 19: 147-158.
15. Buisson A, Lakhmeche N and Verreccgua C et al. (1993) An endogenous anticonvulsant substance. Neuroreport 4: 444-446.
16. Cadenas E and Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222-230.
17. Cao X and Phillis JW (1994) Alpha-phenyl-tert-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res 644:267-272.
18. Carney JM and Floyd RA (1991) Protection against oxidative damage to CNS by alpha-phenyl-tert-butylnitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers. J Mol Neurosci 3:47-57.
19. Cheng Y and Sun AY (1994) Oxidative mechanisms involved in kainite-induced cytotoxicity in cortical neurons. Neurochem Res 19:1557-1564.
20. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
21. Choi DW and Rothman SM (1990) The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Res Neurosci 13:171-182.
22. Chow CK, Ibrahim W, Wei Z and Chan AC (1999) Vitamin E regulates mitochondrial hydrogen peroxide generation. Free Radic Biol Med 27:580-587.
23. Cock HR, Tong X and Hargreaves IP (2002) Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res 48:157-168.
24. Dawson VL (1995) Nitric oxide: role in neurotoxicity. Clin Exp Pharmacol Physiol 22:305-308.
25. Delorenzo RJ, Sun DA and Deshpande LS (2005) Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintenance of epilepsy. Pharmacol Ther 105:229-266.
26. DeSarro GB, DiPaola ED, DeSarrow A and Vidal MJ (1993) L-arginine potentiates excitatory amino acid-induced seizures elicited in the deep pyriform cortex. Eur J Pharmacol 230:151-158.
27. Dettbarn W-D, Milatovic D, Zivin M and Gupta RC (2001) Oxidative stress, acetylcholine and excitoxicity. In: J Marwah and A Kanthasamy (Eds), International Conference on Antioxidants. Scottsdale, AZ: Prominant Press, pp. 183-211.
28. Ehrich M and Jortner BS (2001) Organophosphorous-induced delayed neuropathy. In: R. Krieger (Ed), Handbook of Pesticide Toxicology, 2nd ed. San Diego: Academic Press, pp. 987-1012.
29. + produces progressive neuronal degeneration which is mediated by oxidative stress. Exp Neurol 144:193-198.
30. Famm SS and Morrow JD (2003) The isoprostanes: unique products of arachidonic acid oxidation: a review. Curr Med Chem 10:1723-1740.
31. Fang YZ, Yang S and Guoyao W (2002) Free radicals, antioxidant, and nutricion. Nutrition 18:872-879.
32. Farooqui AA, Yi Ong W, Lu XR, Halliwell B and Horrocks LA (2001) Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A(2) inhibitors. Brain Res Rev 38:61-78.
33. Fetcher LD, Liu Y and Pearce TA (1997) Cochlear protection from carbon monoxide exposure by free radical blockers in the guinea pig. Toxicol Appl Pharmacol 142:47-55.
34. Floyd RA (1997) Protective action of nitrone-based free radical traps against oxidative damage to the central nervous system. Adv Pharmacol 38:361-378.
35. Frederiksson A, Eriksson P and Archer T (1997) MPTP-induced deficits in motor activity: neuroprotective effects of the spin trapping agents, alpha-phenyl-tert-butylnitrone (PBN). J Neural Trans 104:579-592.
36. Gao L, Yin H, Milne GL, Porter NA and Morrow JD (2006) Formation of F-ring isoprostane-like compounds (F3- isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 281:14092-14099.
37. Garcia SJ, Seidler FJ, Crumpton TL and Slotkin TA (2001) Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenyl cyclase signaling, nuclear transcription factors and formation of reactive oxygen in C6 glioma cells. Neurotoxicology 22:129-154.
38. Garthwaite J, Garthwaite G, Palmer RJM and Moncada S (1989) NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 172:413-416.
39. Gido G, Kristian T and Siesjo BK (1997) Extracellular potassium in a neocortical cone area after transient focal ischemia. Stroke 28:206-210.
40. Gollnick PD, Bertocci LA, Kelso TB et al. (1990) The effect of high intensity exercise on the respiratory capacity of skeletal muscle. Pfluger's Arch Eur J Physiol 415:407-413.
41. Grossman W and Jurna I (1977) Die wirkung von memantine auf membranen sensibler nerven faserbundel. Arzneimittel- Forschung 27:1483-1487.
42. Gupta RC and Dettbarn W-D (1992) Potential of memantine, d-tubocurarine and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: soman, sarin, tabun and VX. Neurotoxicology 13:500-514.
43. Gupta RC and Goad J (2000) Role of high-energy phosphates and their metabolites in protection of carbofuran-induced biochemical changes in diaphragm muscle by memantine. Arch Toxicol 74:13-20.
44. Gupta RC and Kadel WL (1989) Prevention and antagonism of acute carbofuran intoxication by memantine and atropine. J Toxicol Environ Health 28:111-122.
45. Gupta RC and Kadel WL (1990) Methyl parathion acute toxicity: prophylaxis and therapy with memantine and atropine. Arch Int Pharmacodynam Ther 305:208-221.
46. Gupta RC and Kadel WL (1991) Novel effects of memantine in antagonizing acute aldicarb toxicity: mechanistic and applied considerations. Drug Dev Res 24:329-341.
47. Gupta RC, Milatovic D and Dettbarn W-D (2001a) Depletion of energy metabolites following acetylcholinesterase inhibitorinduced status epilepticus: protection by antioxidants. Neurotoxicology 22:271-282.
48. Gupta RC, Milatovic D and Dettbarn W-D (2001b) Nitric oxide modulates high-energy phosphates in brain regions of rats intoxicated with diisopropylphosphorofluoridate or carbofuran: prevention by N-tert-butyl-a-phenylnitrone or vitamin E. Arch Toxicol 75:346-356.
49. Gupta RC, Milatovic D, Zivin M and Dettbarn W-D (2001c) Seizure-induced changes in energy metabolites and effects of N-tert-buty-a-phenylnitrone (PBN) and vitamin E. Pfluger's Arch Eur J Physiol 440: R160-R162.
50. Gupta RC, Milatovic S, Dettbarn W-D, Aschner M and Milatovic D (2007) Neuronal oxidative injury and dendritic damage induced by carbofuran: protection by memantine. Toxicol Appl Pharmacol 219:97-105.
51. Haberny KA, Pou S and Eccles CU (1992) Potentiation of quinolinante-produced lesions by inhibition of NO synthesis. Neuroscience 146:187-190.
52. He QP, Smith ML, Li PA and Siesjo BK (1997) Necrosis of the substantia nigra, pars reticulate, in fluorothyl-induced status epilepticus is ameliorated by the spin trap alpha-phenyl-N-tertbutylnitrone. Free Rad Biol Med 22:917-922.
53. Heinemann U, Buchheim K and Gabriel S (2002) Cell death and metabolic activity during epileptiform discharges and status epilepticus in the hippocampus. Prog Brain Res 135:197-210.
54. Jacobsson SOP, Cassel GE and Persson SA (1999) Increased levels of nitrogen oxides and lipid peroxidation in the rat brain after soman induced seizures. Arch Toxicol 73:269-273.
55. Jamal GA (1997) Neurological syndromes of organophosphorous compounds. Adv Drug React Toxic Rev 16:133-170.
56. Jeyarasasingam G, Yeluashvili M and Quik M (2000) Nitric oxide is involved in acetylcholinesterase inhibitor-induced myopathy in rats. J Pharmacol Exp Ther 295:314-320.
57. Johnson MK (1982) The target for initiation of delayed neurotoxicity by organophosphorous esters: biochemical studies and toxicological applications. Rev Biochem Toxicol 4:141-212.
58. Johnson MK and Glynn P (2001) Neuropathy target esterase. In: R. Krieger (Ed), Handbook of Pesticide Toxicology, 2nd ed. San Diego: Academic Press, pp. 953-965.
59. Jones PA, Smith RA and Stone TW (1998) Nitric oxide synthase inhibitors L-NAME and 7-nitroindazole protect rat hippocampus against kainate induced toxicity. Neurosci Lett 249:75-78.
60. Jorgensen MB, Finsen BR, Jensen MB, Castellano B, Diemer NH and Zimmer J (1993) Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus. Exp Neurol 120:70-88.
61. Jourquin J, Tremblay E, Decanis N, Charton G, Hanessian S, Chollet AM, Le Diguardher T, Khrestchatisky M and Rivera S (2003) Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 18:1507-1517.
62. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S, Brot N, Fitzgerald GA, Floyd RA, George M, Heinecke JW, Hatch GE, Hensley K, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts LJ II, Rokach J, Shigenaga MK., Sohal RS, Sun J, Tice RR, Van Thiel DH, Wellner D, Walter PB, Tomer KB, Mason RP and Barrett JC (2005) Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38:698-710.
63. Kast B (2001) The best supporting actors. Science 412:674-676.
64. Kim YB, Hur GH, Lee YS, Han BG and Shin S (1997) A role of nitric oxide in organophosphate-induced convulsions. Environ Toxicol Pharmacol 3:53-61.
65. Kim YB, Hur GH, Shin S et al. (1999) Organophosphateinduced brain injuries: delayed apoptosis mediated by nitric oxide. Environ Toxicol Pharmacol 7:147-152.
66. Knowels RG and Moncada S (1994) Nitric oxide synthase in mammals. Biochem J 289:249-256.
67. Kotegawa M, Sugiyama M, Shoji T, Haramaki N and Orgura R (1993) Effect of a-tocopherol on high energy phosphate metabolite levels in rat heart by 31P-NMR using a Langendorff perfusion technique. J Mol Cell Cardiol 25:1067-1074.
68. Kuroda S, Katsura K, Hillered L et al. (1996) Delayed treatment with alpha-N-tert-bytilnitone (PBN) attenuates secondary mitochondrial dysfunction after transient focal cerebral ischemia in the rats. Neurobiol Dis 3:149-157.
69. Krishna MC, Russo A, Mitchell JB et al. (1996) Do nitroxide antioxidants act as scavengers of O2 or as SOD mimics? J Biol Chem 271:26026-26031.
70. Lafon-Cazal M, Pietri S, Culcasi M and Bockaert J (1993) NMDAdependent superoxide production and neurotoxicity. Nature 364:535-537.
71. Lallement G, Shih TM, Pernot-Marino I, Baubichon D, Foquin A and McDonough JH (1996) The role of nitric oxide in somaninduced seizures, neuropathology, and lethality. Pharmacol Biochem Behav 54:731-737.
72. Lancelot E, Revaud ML, Boulee RG et al. (1997) Alpha-N-tertbytilnitone attenuates excitotoxcicity in rat striatum by preventing hydroxyl radical accumulation. Free Rad Biol Med 23: 1031-1034.
73. Lee SH and Blair IA (2001) Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc Med 11:148-155.
74. Lehtimaki KA, Peltola J, Koskikallio E, Keranen T and Honkaniemi J (2003) Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res Mol Brain Res 110:253-260.
75. Levin HS, Rodnitzky RL and Mick DL (1976) Anxiety associated with exposure to organophosphate compounds. Arc Gen Psychiatry 33:225-228.
76. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568.
77. Lipton SA, Choi YB, Pan ZH et al. (1993) A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide synthase by 7-nitroindazole. Neuroreport 5:1993-1996.
78. Lizasoain I, Moro MA, Knowles RG, Darley-Usmar Vand Moncada S (1996) Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 314:877-880.
79. Lo Pachin RM Jr and Aschner N (1999) Neruonal-glial interactions as potential targets of neurotoxicant effects. In: H. A. Tilson and J. Harry (Eds), Neurotoxicology, 2nd ed. Washington, DC: Taylor & Francis, pp. 53-80.
80. Lotti M (1992) The pathogenesis of organophosphate neuropathy. Crit Rev Toxicol 21:465-487.
81. Lotti M and Moretto A (2005) Organophosphate-induced delayed polyneuropathy. Toxicol Rev 24:37-49.
82. Lowenstein DH and Alldredge BK (1998) Status epilepticus. N Engl J Med 338:970-976.
83. Masuo K, Enomoto KI and Maine T (1986) Effects of memantine on the frog neuromuscular junction. Eur J Pharmacol 130:187-195.
84. McLean MJ, Gupta RC, Dettbarn W-D and Wamil AW (1992) Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol Appl Pharmacol 112:95-103.
85. Milatovic D and Johnson MK (1993) Reactivation of phosphorodiamidated acetylcholinesterase and neuropathy target esterase by treatment of inhibited enzyme with potassium fluoride. Chem Biol Interactions 87:425-430.
86. Milatovic D, Moretto A, Osman KA and Lotti M (1997) Phenyl valerate esterase other than neuropathy target esterase and the promotion of organophosphate polyneuropathy, Chem Res Toxicol 10:1045-1048.
87. Milatovic D, Radic Z, Zivin M and Dettbarn W-D (2000a) Atypical effect of some spin trapping agents: reversible inhibition of acetylcholinesterase. Free Rad Biol Med 28:597-603.
88. Milatovic D, Zivin M and Dettbarn W-D (2000b) The spin trapping agent phenyl-N-tert-butyl-nitrone (PBN) prevents excitotoxicity in skeletal muscle. Neurosci Lett 278:25-28.
89. Milatovic D, Zivin M, Gupta RC and Dettbarn W-D (2001) Alterations in cytochrome-c-oxidase and energy metabolites in response to kainic acid-induced status epilepticus. Brain Res 912:67-78.
90. Milatovic D, Gupta RC and Dettbarn W-D (2002) Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res 957:330-337.
91. Milatovic D, Zaja-Milatovic S, Montine KS, Horner PJ and Montine TJ (2003) Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J Neurochem 87:1518-1526.
92. Milatovic D, Milatovic S, Montine K, Shie FS and Montine TJ (2004) Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immunity response in vivo. J Neuroinflamm 1:20.
93. Milatovic D, Gupta RC, Dekundy A, Montine TJ and Dettbarn W-D (2005a) Carbofuran-induced oxidative stress in slow and fast skeletal muscles: prevention by memantine. Toxicology 208:13-24.
94. Milatovic D, Van Rollins M, Li K, Montine KS and Montine TJ (2005b) Suppression of cerebral oxidative damage from excitotoxicity and innate immune response in vivo by a- or g-tocopherol. J Chromatogr B 827:88-93.
95. Milatovic D, Gupta RC and Aschner M (2006) Anticholinesterase toxicity and oxidative stress. Scientific World Journal 6:295-310.
96. Miyajima T and Kotake Y (1995) Spin trap phenyl-N-tertbutylnitone (PBN) inhibits induction of nitric oxide synthase in endotoxin-induction in mice. Free Rad Biol Med 22:463-470.
97. Miyajima T and Kotake Y (1997) Spin trap phenyl N-tertbutylnitrone (PBN) for the inhibition of nitric oxide synthase induction in mice. Free Rad Biol Med 22:463-470.
98. Montine TJ, Milatovic D, Gupta RC, Morrow JD and Breyer R (2002) Neuronal oxidative damage from activated innate immunity in EP2 receptor-dependent. J Neurochem 83:463-470.
99. Montine KS, Quinn JF, Zhang J, Fessel JP, Roberts LJII, Morrow JD and Montine TJ (2004) Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids 128: 117-124.
100. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF and Roberts LJ II (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387.
101. Munirathinam S and Bahr BA (2004) Repeated contact with subtoxic soman leads to synaptic vulnerability in hippocampus. J Neurosci Res 77:739-746.
102. Nicholls DG and Ward MW (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci 23:166-174.
103. Nicholls DG, Vesce S, Kirk L and Chalmers S (2003) Interactions between mitochondrial bioenergetics and cytoplasmic calcium in cultured cerebellar granule cells. Cell Calcium 34:407-424.
104. O'Brien RJ, Kamboj S, Ehlers MD, Rosen KR, Fischbach GD and Huganir RL (1998) Activity-dependent modulation of synaptic AMPA receptor accumulation. Neuron 21:1067-1078.
105. Pahlmark K and Siesjo BK (1996) Effects of the spin trap-alphaphenyl- N-tert-butylnitrone (PBN) in transient forebrain ischemia in the rat. Acta Physiol Scand 157:41-51.
106. Patel MN (2002) Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Radic Res 36:1139-1146.
107. Pazos AJ, Green EJ, Busto R et al. (1999) Effects of combined postischemic hypothermia and delayed N-tert-butyl-alpha-phenylnitrone (PBN) administration on histopathological and behavioral deficits associated with transient global ischemia. Brain Res 846:186-195.
108. Phillis JW and Clough-Helfman C (1990) Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butylalpha- phenylnitrone (PBN). Neurosci Lett 116:315-319.
109. Pratico D, Rokach J, Lawson J and FitzGerald GA (2004) F2- isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem Phys Lipids 128:165-171.
110. Punz A, Nanobashvili N, Feugl A et al. (1998) Effect of atocopherol pretreatment on high energy metabolites in rabbit skeletal muscle after ischemia-reperfusion. Clin Nutr 17:85-87.
111. Qiao D, Seidler FJ and Slotkin TA (2001) Developmental neurotoxicity of chlorpyrifos modeled in vitro: Comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells. Environ Health Perspect 109:909-913.
112. Rao A and Craig AM (1997) Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron 19:801-812.
113. Rondouin G, Bockaert J and Lerner-Natoli M (1993) Lnitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. Neuroreport 4:1187-1190.
114. Sack CA, Socci DJ, Crandall BM and Arendash GW (1996) Antioxidant treatment with phenyl-alpha-tert-butylnitrone (PBN) improves the cognitive performance and survival of aging rats. Neurosci Lett 205:181-184.
115. Salem N, Kim HY and Lyergey JA (1986) Docosahexaenoic acid: membrane function and metabolism. In: RE Martin (Ed), Health Effects of Polyunsaturated Acids in Seafoods. New York: Academic Press, pp. 263-317.
116. Schulz JB, Huang PL, Mathews RT et al. (1996) Striatal malonate lesions are attenuated in neuronal nitric oxide knockout mice. J Neurochem 67:430-433.
117. Siesjo BK (1988) Historical overview: calcium, ischemia, and death of brain cells. Ann New York Acad Sci 522:638-661.
118. Simonian NA and Coyle JT (1996) Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36:83-106.
119. Singh S and Sharms N (2000) Neurological syndromes following organophosphate poisoning. Neurol India 48:308-313.
120. Soussi B, Idstrom JP, Schersten T and Bylund-Fellenius AC (1989) Kinetic parameters of cytochrome c oxidase in rat skeletal muscle: effect of endurance training. Acta Physiol Scand 135:373-379.
121. Taylor P (1990) Anticholinesterase agents. In: AG Gilman, TW Rall, AS Nies and P Taylor (Eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: Pergamon, pp. 131-149.
122. Thomas CE, Ohlweiler DF, Taylor VL and Schmidt CJ (1997) Radical trapping and inhibition of iron-dependent CNS damage by cyclic nitrone spin traps. J Neurochem 68:1173-1182.
123. Topinka J, Bincova B, Sram RJ and Erin AN (1989) The influence of a-tocopherol and pyritinol on oxidative DNA damage and lipid peroxidation in human lymphocytes. Mutat Res 225:131-136.
124. U.S. Environmental Protection Agency, Office of Pesticide Programs (2002) FY 2002 Annual Report. Washington, DC: U.S. Environmental Protection Agency. Available at www.epa.gov.
125. Van Acker SABE, Koymans LMH and Bast A (1993) Molecular pharmacology of vitamin E: structural aspects of antioxidant activity. Free Radic Biol Med 15:311-328
126. Vezzani A, Moneta D, Richichi C, Aliprandi M, Burrows SJ, Ravizza T, Perego C and De Simoni MG (2002) Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 43:30-35.
127. Wand P, Sontag KH and Kremer H (1977) Effects of 1,3-dimethyl- 5-aminoadamantane hydrochloride (DMAA) on the stretchinduced reflex tension of flexor muscles and excitability of the gamma-loop in decerebrate and spinal cats. Arzneimittel Forschung 27:1477-1481.
128. Wesemann W, Sontag KH and Maj J (1983) Zur Pharmacodynamic und Pharmacokinetic des Memantine. Arzneimittel-Forschung 33: 1122-1134.
129. WHO (World Health Organization) (1986) World Health Organization Metabolism and Mode of Action. Organophosphorus Insecticides: a General Introduction. WHO, Geneva, pp. 39-48.
130. Yang ZP and Dettbarn W-D (1998) Lipid peroxidation and changes of cytochrome c oxidase and xanthine oxidase in organophosphorous anticholinesterase induced myopathy. Xth International Symposium on Cholinergic Mechanisms. J Physiology (Paris) 92:157-162.
131. Yuste R and Denk W (1995) Dendritic spines as basic functional units of neuronal integration. Nature 375:682-684.
132. Zaja-Milatovic S, Gupta RC, Aschner M, Montine TJ and Milatovic D (2008) Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum. Neurotoxicology 29:621-627.
133. Zivin M, Milatovic D and Dettbarn W-D (1999) Nitrone spin trapping compound N-tert-butyl-a-phenylnitrone prevents seizure induced by anticholinesterases. Brain Res 850:63-72.